Synthesis and characterization of actively HER-2 Targeted Fe 3 O 4 @Au nanoparticles for molecular radiosensitization of breast cancer
BioImpacts · 01.01.2023 · 13 (1) · 17-29
DOI: 10.34172/bi.2022.23682 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioImpacts, online erschienen am 15.01.2022. Verfasst von Behnaz Babaye Abdollahi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
The present study was done to assess the effect of molecularly-targeted core/shell of iron oxide/gold nanoparticles (Fe3O4@AuNPs) on tumor radiosensitization of SKBr-3 breast cancer cells.
Methods
Human epidermal growth factor receptor-2 (HER-2)-targeted Fe3O4@AuNPs were synthesized by conjugating trastuzumab (TZ, Herceptin) to PEGylated (PEG)-Fe3O4@AuNPs (41.5 nm). First, the Fe3O4@Au core-shell NPs were decorated with PEG-SH to synthesize PEG-Fe3O4@AuNPs. Then, the TZ was reacted to OPSS-PEG-SVA to conjugate with the PEG-Fe3O4@AuNPs. As a result, structure, size and morphology of the developed NPs were assessed using Fourier-transform infrared (FT-IR) spectroscopy, dynamic light scattering (DLS) and transmission electron microscopy (TEM), and ultraviolet-visible spectroscopy. The SKBr-3 cells were treated with different concentrations of TZ, Fe3O4@Au, and TZ-PEG-Fe3O4@AuNPs for irradiation at doses of 2, 4, and 8 Gy (from X-ray energy of 6 and 18 MV). Cytotoxicity was assessed by MTT assay, BrdU assay, and flow cytometry.
Results
Results showed that the targeted TZ-PEG-Fe3O4@AuNPs significantly improved cell uptake. The cytotoxic effects of all the studied groups were increased in a higher concentration, radiation dose and energy-dependent manner. A combination of TZ, Fe3O4@Au, and TZ-PEG-Fe3O4@AuNPs with radiation reduced cell viability by 1.35 (P=0.021), 1.95 (P=0.024), and 1.15 (P=0.013) in comparison with 8 Gy dose of 18 MV radiation alone, respectively. These amounts were obtained as 1.27, 1.58, and 1.10 for 8 Gy dose of 6 MV irradiation, respectively.
Conclusion
Radiosensitization of breast cancer to mega-voltage radiation therapy with TZ-PEG-Fe3O4@AuNPs was successfully obtained through an optimized therapeutic approach for molecular targeting of HER-2.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Medical Physics, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Nutration Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Imam Reza Educational Hospital, Radiotherapy Department, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Behnaz Babaye Abdollahi, Alireza Farajollahi
Zitieren
APA
Babaye Abdollahi, B., Ghorbani, M., Hamishehkar, H., Malekzadeh, R., & Farajollahi, A. (2023). Synthesis and characterization of actively HER-2 Targeted Fe 3 O 4 @Au nanoparticles for molecular radiosensitization of breast cancer. BioImpacts, 13(1), 17-29. https://doi.org/10.34172/bi.2022.23682
Vancouver
Babaye Abdollahi B, Ghorbani M, Hamishehkar H, Malekzadeh R, Farajollahi A. Synthesis and characterization of actively HER-2 Targeted Fe 3 O 4 @Au nanoparticles for molecular radiosensitization of breast cancer. BioImpacts. 2023;13(1):17-29. doi:10.34172/bi.2022.23682
BibTeX
@article{BabayeAbdollahi2023,
author = {Babaye Abdollahi, Behnaz and Ghorbani, Marjan and Hamishehkar, Hamed and Malekzadeh, Reza and Farajollahi, Alireza},
title = {Synthesis and characterization of actively HER-2 Targeted Fe 3 O 4 @Au nanoparticles for molecular radiosensitization of breast cancer},
journal = {BioImpacts},
year = {2023},
volume = {13},
number = {1},
pages = {17--29},
doi = {10.34172/bi.2022.23682}
}
EUVIMED